Carl Zeiss Meditec’s re-rating journey should continue further
21/02/24 -"Despite our near-term estimates being slightly moderated due to the destocking of consumables and anticipated impact from volume-based procurement headwinds, our target price resets higher by c.4%, ..."
Pages
65
Language
English
Published on
21/02/24
You may also be interested by these reports :
11/12/24
CZM’s FY2023-24 operational performance came in line with the management’s expectations, as a weaker investment climate in North America and soft ...
05/12/24
Since we last teased the in-vitro diagnostics player DiaSorin (Add; Italy) in August 2023, the Italian firm has seen its dreams become reality. The ...
02/12/24
Even though Philips and Siemens Healthineers share a decent overlap in business areas and Philips has a better report card in terms of stakeholder ...
27/11/24
Elekta’s Q2 results missed the street’s expectations. Topline growth declined by a mid-single digit percentage as healthy growth in Service was more ...